08 Jun 2020

VS MOVES ITS JULY CONFERENCE ONLINE

  The Venous Symposium announced June 8 that its July 31-Aug. 2 conference in New York City will be a virtual conference from 10 a.m.-2 p.m. on the same dates, and there will be on-demand access to the educational program and exhibit hall for an entire year. There is an

0
07 Jun 2020

A REPORT FROM ‘FLYOVER COUNTRY:’Many practices may fail despite being in areas without COVID-19 cases

By Stephen F. Daugherty One of the most remarkable aspects of the COVID-19 crisis in the United States is the very different experience depending upon where one lives and practices medicine. As of May 10, the county in which I live and practice in Tennessee has experienced two tragic COVID

0
05 Jun 2020

REOPENING & RECOVERING: Aspects of disaster recovery from the COVID-19 shutdown

  By David Schmiege I have had countless conference calls with clients over the past 8-10 weeks as practices contemplate the necessary steps to reopen their vein practices and regain their momentum. The COVID-19 pandemic is wreaking havoc on our economy. As with many small businesses, the pandemic has had

0
21 May 2020

IVC 2020 CANCELLED

The 18th Annual International Vein Congress, scheduled for July 9-11 at the Loews Miami Beach Hotel in collaboration with the Society for Vascular Surgery, has been cancelled. “ I just cancelled IVC today,” Jose I. Almeida, MD, FACS, told Vein Therapy News May 21. “We’ll be doing some video and

0
08 May 2020

THE TSA HOARDED 1.3 MILLION N95 MASKS EVEN THOUGH AIRPORTS ARE EMPTY AND IT DOESN’T NEED THEM

new graph       TSA officials stockpiled a huge shipment of N95 masks they knew they didn’t need even after two agency officials asked to donate them. Airport traffic fell 95 percent, and the masks have sat unused as hospitals searched desperately for them.   By J. David McSwane

0
06 May 2020

RADIOLOGY MUST REGAIN PUBLIC’S TRUST IN WAKE OF COVID-19

  By  Louise Gagnon As radiology braces for a surge in imaging procedures in the aftermath of the COVID-19 pandemic, facilities must take steps to regain the public’s trust that they can undergo imaging exams safely, according to Dr. Mahmud Mossa-Basha, chief of radiology at the University of Washington. Radiology

0
04 May 2020

REMDESIVIR: GILEAD IS DONATING ITS SUPPLY, BUT WHAT’S A FAIR PRICE?

  How much should Gilead Sciences charge for its now-authorized COVID-19 therapy remdesivir? Up to $4,460 per patient, an influential pricing watchdog figures. While Gilead has yet to present a marketing plan for the first coronavirus treatment to have shown clinical benefits in a well-designed randomized study, the Institute for Clinical and

0
24 Apr 2020

SIGVARIS GROUP CELEBRATES WORLD LYMPHEDEMA DAY

  SIGVARIS GROUP is participating in World Lymphedema Day to spread awareness and support the continues search for a cure. World Lymphedema Day is an annual advocate-driven worldwide celebration established in 2016 by the US Senate in response to a bill written by the Lymphatic Education & Research Network (LE&RN)

0
01 Apr 2020

MAJOR MEDICAL STAFFING COMPANY JUST SLASHED BENEFITS FOR DOCTORS AND NURSES FIGHTING CORONAVIRUS

Alteon Health, backed by private-equity firms Frazier Healthcare Partners and New Mountain Capital, will cut salaries, time off and retirement benefits for providers, citing lost revenue. Several hospitals announced similar cuts. By Isaac Arnsdorf   Emergency room doctors and nurses many of whom are dealing with an onslaught of coronavirus patients

0
31 Mar 2020

U.S. TAXPAYERS PAID MILLIONS TO DESIGN A LOW-COST VENTILATOR FOR A PANDEMIC: INSTEAD, A ROYAL PHILIPS N.V. SUBSIDIARY IS SELLING VERSIONS OF IT OVERSEAS.

    By Patricia Callahan, Sebastian Rotella and Tim Golden ProPublica   Five years ago, the U.S. Department of Health and Human Services tried to plug a crucial hole in its preparations for a global pandemic, signing a $13.8 million contract with a Pennsylvania manufacturer to create a low-cost, portable, easy-to-use ventilator that

0